Clinical TrialsSearch results
Number of results: 498
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- Phase III Clinical Study on Taste Disorder by Z-103 -Double Blind Comparison Study on Patients with Zinc-Deficient and Idiopathic Taste Disorders -
- Zinc-Deficient and Idiopathic Taste Disorders
- ZERIA Pharmaceutical Co.,Ltd.
- 2006-04-10
Other
- Phase III Clinical Study on ART-123 in patients with disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections (Multicenter double-blind randomized parallel group comparative study with heparin sodium as control drug)
- Disseminated intravascular coagulation (DIC) directly caused by malignant hematopoietic tumors or infections
- Asahi Kasei Pharma Corporation
- 2006-02-07
Other
- Phase II trial of combination chemotherapy consisting of S-1 and Oxaliplatin in patients with advanced or recurrent mucinous adenocarcinoma of the ovary
- Mucinous adenocarcinoma of the ovary including metastatic ovarian cancer
- Japan ovarian mucinous adenocarcinoma study group
- 2009-01-01
Other
- Phase II study of TS-1, CPT-11 and Bevacizumab combination chemotherapy in patients with metastatic colon cancer
- Metastatic colorectal cancer
- Multicenter Clinical Study Group of Osaka, Colorectal Cancer Treatment Group
- 2012-01-16
Other
- Phase II study of topotecan and cisplatin for elderly small-cell lung cancer
- Elderly small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Phase II study of topotecan and amrubicin for metastatic or relapsed small-cell lung cancer
- Metastatic or relapsed small-cell lung cancer
- Okayama Lung Cancer Study Group
- 2005-09-12
Other
- Phase II Study of Thymomectomy for Thymoma Localized in the Thymus
- thymoma
- Japanese Association for Research on the Thymus
- 2007-04-01
Other
- Phase II study of SMILE chemotherapy for stage IV or relapsed/refractory extranodal NK/T-cell lymphoma
- extranodal NK/T-cell lymphoma, nasal type
- NK-cell Tumor Study Group
- 2007-05-14
Other
- Phase II study of sequential administration of FEC (Fluorouracil / Epirubicin / Cyclophosphamide) followed by Docetaxel as adjuvant chemotherapy for node-positive breast cancer
- Breast cancer
- Kyushu Breast Cancer Study Group
- 2006-04-06
Other
- Phase II study of rituximab in refractory or relapsed patients with multiple myeloma expressing CD20
- Multiple myeloma expressing CD20
- Zenyaku Kogyo Co., Ltd.
- 2006-11-28